ClinicalTrials.gg
CompletedNCT03401983Updated Jan 17, 2018

Effectiveness of Pelvic Floor Muscle and Abdominal Training in Women With Stress Urinary Incontinence

An interventional study of Pelvic Floor Muscle Training and Abdominal Training and Pelvic Floor Muscle Training in Stress Urinary Incontinence and Pelvic Floor Muscle Weakness, sponsored by Trakya University. Completed. Open to female participants aged 18 Years to 49 Years. Per ClinicalTrials.gov, last updated 2018-01-17.

Sponsored by Trakya University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 4 months after the study started (first participant enrolled Sep 2016, registered Jan 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years to 49 Years
Sex
Female
01

Study summary

The aim of this study was to investigate the effectiveness of pelvic floor muscle and abdominal training in reproductive-age patients with stress urinary incontinence.

This prospective randomized controlled design study included 64 female patients aged 18-49 years with stress urinary incontinence. The patients were divided into 2 groups (32 PFMT "Pelvic Floor Muscle Training" and 32 PFMT+AT "Abdominal Training") by computer-based randomization. The stress urinary incontinence type was assessed by a stress test, and the pelvic floor muscle strength was measured with a home biofeedback device. Voiding functions were assessed by a 3-day voiding diary and uroflowmetric test. The UDI-6 scale was used to assess the urinary symptoms, and the IIQ-7 scale was used to assess the quality of life. The follow-up measurements of both groups were obtained in the 0th, 4th, and 8th weeks.

Read the detailed description

The aim of this study was to investigate the effectiveness of pelvic floor muscle and abdominal training in reproductive-age patients with stress urinary incontinence.

This prospective randomized controlled design study included 64 female patients aged 18-49 years with stress urinary incontinence. The patients were divided into 2 groups (32 PFMT "Pelvic Floor Muscle Training" and 32 PFMT+AT "Abdominal Training") by computer-based randomization. The stress urinary incontinence type was assessed by a stress test, and the pelvic floor muscle strength was measured with a home biofeedback device. Voiding functions were assessed by a 3-day voiding diary and uroflowmetric test. The UDI-6 scale was used to assess the urinary symptoms, and the IIQ-7 scale was used to assess the quality of life. The follow-up measurements of both groups were obtained in the 0th, 4th, and 8th weeks.

Participation of 29 patients from each group in the study was determined as sufficient to test the two-way hypothesis, with an effect size of 0.75, with an alpha level of 0.05, and with a power of 80%. However, 32 patients from each group were included as a precaution against possible missing data.

These women were randomly divided into the PFMT+AT (n=32) and PFMT (n=32) groups using a computer based randomization scheme. The data were collected from both groups at the 0th, 4th, and 8th weeks.

02

Conditions studied

  • Stress Urinary Incontinence
  • Pelvic Floor Muscle Weakness

Keywords

  • exercise
  • pelvic floor
  • stress urinary incontinence
03

In context

Urinary Incontinence, Stress

651 studies on the registry are indexed under Urinary Incontinence, Stress; 120 are open to participants now.

This study's enrollment of 64 is close to the median of 68 across 506 interventional studies indexed under Urinary Incontinence, Stress.

Browse Urinary Incontinence, Stress studies →

Lead sponsor

Trakya University is the lead sponsor of 155 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 49 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18-49 years
  • Meet the diagnosis of simple female stress urinary incontinence (Degree 0 or 1)
  • Volunteer to participate the study

Exclusion criteria

Exclusion Criteria

  • ≥30
  • Hysterectomy, urinary incontinence or pelvic floor operations
  • Chronic health problem (cardiovascular, cerebral, diabetes, liver, kidney, psychiatric disease, etc.)
  • Urge urinary incontinence, mixed urinary incontinence, overflow urinary incontinence
  • SUI Degree ≥2
  • Symptomatic urinary tract infection
  • During pregnancy or lactation period
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
64 participants (actual)

Study arms

  • Experimental
    PFMT + AT

    Pelvic Floor Muscle Training and Abdominal Training

    Other: Pelvic Floor Muscle Training and Abdominal Training

  • Active comparator
    PFMT

    Pelvic Floor Muscle Training

    Other: Pelvic Floor Muscle Training

Interventions

  • OtherPelvic Floor Muscle Training and Abdominal Training

    Pelvic Floor Muscle Training + Abdominal Training program was used in the study. The follow-up measurements of the PFMT+AT group were obtained in the 0th, 4th, and 8th weeks.

  • OtherPelvic Floor Muscle Training

    Pelvic Floor Muscle Training program was used in the study. The follow-up measurements of the PFMT group were obtained in the 0th, 4th, and 8th weeks.

06

What researchers measure

Primary outcomes

  1. Change from baseline pelvic floor muscle strength at 8 weeks

    Pelvic floor muscle strength was measured using a perineometry device

    Time frame: 0th, 4th, and 8th weeks.

Secondary outcomes

  1. Change from baseline UDI-6 score at 8 weeks

    Urinary symptoms were measured using the Urinary Distress Inventory (UDI-6)

    Time frame: 0th, 4th, and 8th weeks.

  2. Change from baseline IIQ-7 score at 8 weeks

    Urinary symptoms were measured using the Incontinence Impact Questionnaire (IIQ-7),

    Time frame: 0th, 4th, and 8th weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2016 to primary completion in Mar 2017, 6 months.

Of 225 non-industry interventional studies with no phase under Urinary Incontinence, Stress, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 6 months is below that.

Counting every sponsor, half of 266 studies reached it within 19 months; a quarter within 9 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 2, 2018
First posted
Jan 17, 2018
StartActual
Sep 1, 2016
Primary completionActual
Mar 31, 2017
CompletionActual
Mar 31, 2017
Last update
Jan 17, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 17, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03401983
Lead sponsor
Trakya University
Responsible party
Hatice Kahyaoglu Sut (Head of Department of Obstetrics and Gynecology Nursing, Trakya University) — Principal investigator
First posted
Jan 17, 2018
Start date
Sep 1, 2016
Primary completion
Mar 31, 2017
Completion
Mar 31, 2017
Last update
Jan 17, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion